Who
Bruce D. Steel
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Equillium.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Oct 2018
- Last trade
- 7 Jan 2026
- Last filed
- 9 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Jan 2026filed 9 Jan 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,750,000 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,750,000 at $0.00 | filing |
| 29 Aug 2025filed 3 Sep 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,695,000 at $0.00 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,352 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —44,352 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —100,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —60,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,110 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —100,110 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —245,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —245,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —325,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —325,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —410,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —410,000 | filing |
| 2 Jan 2025filed 6 Jan 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —410,000 at $0.00 | filing |
| 2 Jan 2024filed 3 Jan 2024 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —410,000 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —410,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.